Empagliflozin mitigates type 2 diabetes-associated peripheral neuropathy: a glucose-independent effect through AMPK signaling
Noha F. Abdelkader(Cairo University), Sherehan M. Ibrahim(Cairo University)
Cited by 46
Related Papers
Neuroprotective effect of liraglutide in an experimental mouse model of multiple sclerosis: role of AMPK/SIRT1 signaling and NLRP3 inflammasome
|Inflammopharmacology|2022|73
Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit
|Frontiers in Endocrinology|2021|66